Illinois Municipal Retirement Fund Has $6.13 Million Position in Axon Enterprise, Inc (NASDAQ:AXON)

Illinois Municipal Retirement Fund lessened its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 12.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,658 shares of the biotechnology company's stock after selling 1,635 shares during the quarter. Illinois Municipal Retirement Fund's holdings in Axon Enterprise were worth $6,132,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Brighton Jones LLC acquired a new stake in Axon Enterprise during the 4th quarter valued at $480,000. IFP Advisors Inc raised its holdings in Axon Enterprise by 7.6% during the 4th quarter. IFP Advisors Inc now owns 952 shares of the biotechnology company's stock worth $566,000 after purchasing an additional 67 shares during the last quarter. Lake Street Advisors Group LLC acquired a new position in Axon Enterprise during the 4th quarter valued at about $225,000. New York Life Investment Management LLC boosted its stake in shares of Axon Enterprise by 1.2% in the 4th quarter. New York Life Investment Management LLC now owns 9,721 shares of the biotechnology company's stock valued at $5,777,000 after purchasing an additional 115 shares during the last quarter. Finally, Private Trust Co. NA grew its position in shares of Axon Enterprise by 402.3% during the 4th quarter. Private Trust Co. NA now owns 442 shares of the biotechnology company's stock worth $263,000 after buying an additional 354 shares during the period. Institutional investors and hedge funds own 79.08% of the company's stock.

Wall Street Analyst Weigh In

AXON has been the subject of a number of analyst reports. Needham & Company LLC lifted their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. Bank of America increased their price target on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. Barclays boosted their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Finally, Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $699.55.

Insider Transactions at Axon Enterprise

In other news, CFO Brittany Bagley sold 3,400 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $700.00, for a total value of $2,380,000.00. Following the transaction, the chief financial officer owned 131,833 shares of the company's stock, valued at approximately $92,283,100. This represents a 2.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CRO Cameron Brooks sold 3,000 shares of the business's stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $740.76, for a total transaction of $2,222,280.00. Following the completion of the sale, the executive directly owned 19,447 shares of the company's stock, valued at approximately $14,405,559.72. The trade was a 13.36% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 44,642 shares of company stock worth $30,500,428. 4.40% of the stock is currently owned by insiders.

Axon Enterprise Stock Up 1.1%

NASDAQ:AXON traded up $9.34 during trading hours on Monday, reaching $827.94. 529,854 shares of the stock were exchanged, compared to its average volume of 711,439. The firm has a 50 day moving average of $714.97 and a 200 day moving average of $630.42. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62. Axon Enterprise, Inc has a twelve month low of $279.02 and a twelve month high of $830.21. The stock has a market cap of $64.46 billion, a PE ratio of 199.99, a PEG ratio of 94.23 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The firm had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. During the same quarter in the previous year, the business earned $1.15 earnings per share. The business's revenue was up 31.3% compared to the same quarter last year. On average, equities analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.